READ-ONLY DIGITIZATION RESULT
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.
Br J Haematol · 2026-Mar · PMID 41571607
Panel B提取完成待 EXE 对齐验证
Progression-free survival (Investigator)
FIGURE 2 Kaplan–Meier curve of PFS as assessed by (A) IRC and (B) Investigator. HR, based on the stratified Cox proportional hazards model, with stratification factors: Deletion 17p presence and receipt of prior venetoclax treatment. Two‐sided p ‐value is based on the stratified log‐rank test for comparing pirtobrutinib versus BendaR. BendaR, bendamustine+rituximab; CI, confidence interval; HR, hazard ratio; IRC, independent review committee; NR, not reached; PFS, progression‐free survival.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.9574 | 100.0000 | 64 | 80 | |
| 1 | 2 | 0.0016 | 0.9574 | 100.0000 | 65 | 80 | |
| 1 | 3 | 0.0031 | 0.9574 | 100.0000 | 66 | 80 | |
| 1 | 4 | 0.0047 | 0.9539 | 100.0000 | 67 | 81 | |
| 1 | 5 | 0.0062 | 0.9504 | 100.0000 | 68 | 82 | |
| 1 | 6 | 0.0078 | 0.9433 | 100.0000 | 69 | 84 | |
| 1 | 7 | 0.0093 | 0.9362 | 99.2281 | 70 | 86 | |
| 1 | 8 | 0.0109 | 0.9326 | 98.8421 | 71 | 87 | |
| 1 | 9 | 0.0124 | 0.9291 | 98.4561 | 72 | 88 | |
| 1 | 10 | 0.0140 | 0.9291 | 98.4561 | 73 | 88 | |
| 1 | 11 | 0.0155 | 0.9291 | 98.4561 | 74 | 88 | |
| 1 | 12 | 0.0171 | 0.9291 | 98.4561 | 75 | 88 | |
| 1 | 13 | 0.4006 | 0.4574 | 47.1228 | 322 | 221 | |
| 1 | 14 | 0.4022 | 0.4539 | 46.7368 | 323 | 222 | |
| 1 | 15 | 0.4037 | 0.4539 | 46.7368 | 324 | 222 | |
| 1 | 16 | 0.4053 | 0.4539 | 46.7368 | 325 | 222 | |
| 1 | 17 | 0.4068 | 0.4539 | 46.7368 | 326 | 222 | |
| 1 | 18 | 0.4084 | 0.4539 | 46.7368 | 327 | 222 | |
| 1 | 19 | 0.5637 | 0.4539 | 46.7368 | 427 | 222 | |
| 1 | 20 | 0.5652 | 0.4539 | 46.7368 | 428 | 222 | |
| 1 | 21 | 0.5668 | 0.4539 | 46.7368 | 429 | 222 | |
| 1 | 22 | 0.5683 | 0.4539 | 46.7368 | 430 | 222 | |
| 1 | 23 | 0.5699 | 0.4539 | 46.7368 | 431 | 222 | |
| 2 | 1 | 0.0000 | 0.8369 | 88.4211 | 64 | 114 | |
| 2 | 2 | 0.0016 | 0.8369 | 88.4211 | 65 | 114 | |
| 2 | 3 | 0.0031 | 0.8369 | 88.4211 | 66 | 114 | |
| 2 | 4 | 0.0047 | 0.8369 | 88.4211 | 67 | 114 | |
| 2 | 5 | 0.0062 | 0.8369 | 88.4211 | 68 | 114 | |
| 2 | 6 | 0.0078 | 0.8369 | 88.4211 | 69 | 114 | |
| 2 | 7 | 0.0093 | 0.8369 | 88.4211 | 70 | 114 | |
| 2 | 8 | 0.0109 | 0.8369 | 88.4211 | 71 | 114 | |
| 2 | 9 | 0.0124 | 0.8369 | 88.4211 | 72 | 114 | |
| 2 | 10 | 0.0140 | 0.8369 | 88.4211 | 73 | 114 | |
| 2 | 11 | 0.0155 | 0.8369 | 88.4211 | 74 | 114 | |
| 2 | 12 | 0.0171 | 0.8369 | 88.4211 | 75 | 114 | |
| 2 | 13 | 0.0186 | 0.8404 | 88.8070 | 76 | 113 | |
| 2 | 14 | 0.0202 | 0.8546 | 90.3509 | 77 | 109 | |
| 2 | 15 | 0.0217 | 0.8546 | 90.3509 | 78 | 109 | |
| 2 | 16 | 0.3106 | 0.6028 | 62.9474 | 264 | 180 | |
| 2 | 17 | 0.3121 | 0.5993 | 62.5614 | 265 | 181 | |
| 2 | 18 | 0.3137 | 0.5993 | 62.5614 | 266 | 181 | |
| 2 | 19 | 0.3152 | 0.5993 | 62.5614 | 267 | 181 | |
| 2 | 20 | 0.3168 | 0.5922 | 61.7895 | 268 | 183 | |
| 2 | 21 | 0.3183 | 0.5816 | 60.6316 | 269 | 186 | |
| 2 | 22 | 0.3991 | 0.4610 | 47.5088 | 321 | 220 | |
| 2 | 23 | 0.4006 | 0.4574 | 47.1228 | 322 | 221 | |
| 2 | 24 | 0.4022 | 0.4574 | 47.1228 | 323 | 221 | |
| 2 | 25 | 0.4037 | 0.4574 | 47.1228 | 324 | 221 | |
| 2 | 26 | 0.4053 | 0.4539 | 46.7368 | 325 | 222 | |
| 2 | 27 | 0.4068 | 0.4539 | 46.7368 | 326 | 222 | |
| 2 | 28 | 0.5621 | 0.4539 | 46.7368 | 426 | 222 | |
| 2 | 29 | 0.5637 | 0.4539 | 46.7368 | 427 | 222 | |
| 2 | 30 | 0.5652 | 0.4539 | 46.7368 | 428 | 222 | |
| 2 | 31 | 0.5668 | 0.4539 | 46.7368 | 429 | 222 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-18T20:46:36+00:00 |